Science Explorer Interactive view Map
Company · Braine-l'Alleud · Belgium

Bristol-Myers Squibb (Belgium)

bms.com/beROR OpenAlex
World rank, all time
#19,832
of 42,892
Rank in Belgium
#127
of 267
Research works
194
▲ 58% vs 2013–17
Citations
5.8k
30.2 per fractional work
Top-10% rate
19.2%
record average 16.5%
Open access
35%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.63× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 4.20× its world share, 2 worksImmunology and Micro…Neuroscience: 0.25× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.35× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.00× its world share, 1 worksChemistryComputer Science: 0.51× its world share, 2 worksComputer ScienceEngineering: 0.09× its world share, 1 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMathematics: 4.14× its world share, 2 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.22× its world share, 0 worksHealth ProfessionsMedicine: 2.93× its world share, 23 worksMedicineNursing: 1.72× its world share, 0 worksNursingDecision Sciences: 2.36× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.15× its world share, 2 worksEconomics, Econometr…Psychology: 0.60× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.3×. Every wedge is a field page.

Who are the top researchers at Bristol-Myers Squibb (Belgium)?

Ranked on the composite score, Laure Lacoin lead among researchers whose main affiliation is Bristol-Myers Squibb (Belgium).

  1. 1 Laure Lacoin Belgium · #1,435,856 worldwide 4 citations · 15 works
All ranked researchers at Bristol-Myers Squibb (Belgium)

Which keywords describe research at Bristol-Myers Squibb (Belgium)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Clinical Trials, Chemotherapy, Targeted Therapy, Tumor Microenvironment, Biomarkers, Genomic Profiling and Immune Checkpoint Blockade.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Immunotherapy4▲ 13×14 topics
  2. Clinical Trials3▲ 12×8 topics
  3. Chemotherapy3▲ 9.6×11 topics
  4. Targeted Therapy2▲ 28×4 topics
  5. Tumor Microenvironment2▲ 12×5 topics
  6. Biomarkers2▲ 7.2×7 topics
  7. Epidemiology2▲ 1.21×21 topics
  8. Genomic Profiling2▲ 40×2 topics
  9. Inflammation2▲ 1.94×22 topics
  10. Quality of Life2▲ 2.8×5 topics
  11. Immune Checkpoint Blockade2▲ 36×1 topic
  12. PD-1 and PD-L12▲ 36×1 topic
  13. Guidelines1▲ 7.0×4 topics
  14. ALK Inhibitors1▲ 50×1 topic
  15. Cancer1▲ 2.4×15 topics
  16. Cancer Therapy1▲ 5.8×10 topics
  17. Cost-effectiveness Analysis1▲ 37×1 topic
  18. EGFR Mutations1▲ 50×1 topic
  19. Health Utility Measures1▲ 37×1 topic
  20. Tumor Staging1▲ 28×2 topics
  21. Adjuvant Therapy1▲ 24×2 topics
  22. Bayesian Methods1▲ 58×2 topics
  23. Catheter Ablation1▲ 24×2 topics
  24. Prognostic Factors1▲ 6.5×5 topics
  25. Anticoagulant Therapy1▲ 22×2 topics
  26. Treatment1▲ 2.2×10 topics
  27. Atrial Fibrillation1▲ 25×1 topic
  28. Radiation Therapy1▲ 19×2 topics
  29. Radiotherapy1▲ 6.5×3 topics
  30. Stroke Prevention1▲ 21×1 topic

Which research topics does Bristol-Myers Squibb (Belgium) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Health Systems, Economic Evaluations, Quality of Life and Statistical Methods in Clinical Trials.

Cancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksStatistical Methods in C…1Statistical Methods in Clinical Trials: 1 fractional worksAtrial Fibrillation Management and Outcomes: 1 fractional worksLung Cancer Diagnosis and Treatment: 1 fractional worksOccupational and environ…1Occupational and environmental lung diseases: 1 fractional worksCancer Genomics and Diagnostics: 1 fractional worksCAR-T cell therapy research: 1 fractional worksVenous Thromboembolism Diagnosis and Management: 0 fractional works
OncologyPulmonary and Respiratory MedicineEconomics and EconometricsStatistics and Probability3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  4. 4 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  5. 5 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works
  6. 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  7. 7 Occupational and environmental lung diseases Pulmonary and Respiratory Medicine 1 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 1 works
  9. 9 CAR-T cell therapy research Oncology 1 works
  10. 10 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 28% of research is openly available.

with international co-authors77.9%domestic only22.1%

World: 19% is written across borders.

How has Bristol-Myers Squibb (Belgium)'s research output changed?

Output in 2018–2022 was 58% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.